Company intelligence / Profile preview

Graceway Pharmaceuticals

Bristol, Tennessee, United States
Ownership
Private
Employees
~58
Development stage
Commercial
01

Overview

Graceway Pharmaceuticals was a specialty pharmaceutical company focused on acquiring and developing branded prescription products primarily in dermatology but also respiratory and women's health. Its lead commercial assets included topical immune response modifiers like Aldara® and Zyclara® for actinic keratoses/warts/carcinoma. The company filed for bankruptcy in September 2011 after which its product portfolio—including several mid-to-late-stage pipeline assets—was acquired by Medicis Pharmaceutical Corporation. At the time of sale, annual revenues exceeded $125 million from approved products.

Therapeutic areas
OncologyDermatologyInfectious Diseases
Modalities
Small moleculesTopical creamsInhalersTransdermal delivery systems
Industry
Biotech
02

Drug pipeline

4 assets

imiquimod

Commercial
Indications
Actinic keratosis, External genital warts, Superficial basal cell carcinoma

3 more assets in the full pipeline.

Request access →
03

Partnerships

GTCR Golder Rauner LLC was a founding investor/private equity partner.Pfizer provided early-stage dermatological molecules through an Acquisition & License Agreement.

Beyond the preview

Go deeper on Graceway Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Graceway Pharmaceuticals.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call